Most Commented
- Cubadebate opens its new Web page in English| 20
- Mandela is dead: Why hide the truth about Apartheid?| 11
- El Paso Diary: The Battle Over the Solo Fax| 10
- President Hugo Chavez's address to the People of Venezuela| 10
- Free the Five is heard at Left Forum| 6
- May every citizen be a constituent| 6
- Raúl receives Kim Yong Chol, Special Envoy of the President of the Workers’ Party of Korea| 6
- The Unsustainable Position of the Empire| 5
- U.S. government promoting Internet aggression against Cuba| 5
- NATO’s Genocidal Role| 4
- The Fiftieth Anniversary Parade| 4
- El Paso Diary: The Tip of the Iceberg| 4
Series
- Cuba's Reasons
- Cuban Five
- El Paso Diary
The El Paso Diary is written by José Pertierra--an attorney who represents the government of Venezuela in its request for the extradition of Luis Posada Carriles. Pertierra´s journals describe the testimony, evidence, legal skirmishes, quirks and follies of this very historic trial that features for the first time the close collaboration of the United States government with Cuban authorities to prosecute an ex CIA agent who is one of the masterminds of the fifty-year old dirty war against Cuba.
Authors
- Bernie Dwyer
- Bruno Rodríguez Parrilla
- Deisy Francis Mexidor
- Fidel Castro Ruz
- José Pertierra
- Raúl Castro Ruz
- Ricardo Alarcón de Quesada
- Amy Goodman
- Arleen Rodríguez Derivet
- Frei Betto
- Hugo Chávez Frías
- Josh R. Nelson
- Juan Gelman
- Luis Rumbaut
- Michael Moore
- Mumia Abu-Jamal
- Noam Chomsky
- Reinaldo Taladrid Herrero
- Richard Gott
- Tom Hayden
Articles of Science
News »
Soberana 02 clinical trials expanded
Expanded phase II B clinical trials of Cuba’s anti-COVID-19 candidate vaccine Soberana 02 with volunteers between 19 and 80 years of age, began at the 19 de Abril and No.1 Polyclinics, in the Havana municipalities of Plaza de la Revolución and La Lisa, respectively. For the purpose of evaluating reactions, safety and immunogenicity of the candidate, created by the Finlay Vaccine Institute, volunteers will receive two doses of the drug, administered intramuscularly.
News »
Vaccines and Sovereignty II: What are Vaccines?
The molecules of an invading biological entity that are identified and are accessible to the human immune system are often referred to as “antigens”. They are usually expressed in the outermost parts of the nanoscopic carrier and are a necessary part of its composition. They are the same when found in a virus, in a fungus, in a bacterium, or in the cells of an organ from another being transplanted into our body.
News »
Cuba has confidence in its universities
President of the Republic Miguel Díaz-Canel Bermúdez visited the José Antonio Echeverría Technological University in Havana (CUAJE) yesterday, and while interacting with students and professors commented, “Your experience … is like the “magical realism” of Carpentier, which seems so common to us that we can overlook the greatness of what we do every day. Just enduring the blockade every day… is huge. We need to share these things… position them on media networks; make them visible.”
News »
Vaccines and Sovereignty (I): The virus and the immune system
The word we all speak today with hope is “vaccine.” We have had an absolutely extraordinary 2020’s year. An unexpected and unprecedented pandemic has changed everything, in almost every way for the worse, although there also have been some good consequences. The political defeat of some enemies of our country who did not even know how to lead their powerful country in these extraordinary conditions may have been influenced by this factor, and that is a good consequence.
News »
Cuban science focuses on food security and sustainable development
The Center for Environmental Research (CIMAC) in Camagüey province is promoting projects that respond to the Agenda 2030 for Sustainable Development approved by the United Nations, and which seeks food security. “With an integrated view with the academia, our scientific work has as a premise the environmental management as a support to the sustainable advance of tourism, food production and other economic-social spheres,’ stated the director of the institution, Nereyda Junco.
News »
New horizons for science and innovation
Armando Rodríguez Batista, Deputy Minister of Science, Technology and Environment (Citma), explained to Granma that these norms were the first of a much more comprehensive legal package which continues to be presented (Decree 2/2020 on Advanced Technology Enterprises, Decree Law 7/2020 and its complementary provisions), to guide implementation of policies to perfect Cuba’s science, technology and innovation system, approved by the Council of Ministers in October of 2018.
News »
Clinical trials of Mambisa and Abdala candidate vaccines approved
After a careful review of the information presented, including evidence from pharmaceutical development and studies in animals, the Center for the State Control of Drugs, Equipment and Medical Devices (Cecmed), authorized the clinical trials of two new Cuban candidate vaccines to prevent COVID-19, given the names of Mambisa (CIGB-669) and Abdala (CIGB-66). Trials of the first, created by researchers at the Genetic Engineering and Biotechnology Center (CIGB), affiliated with the BioCubaFarma Enterprise Group
News »
Cuba presents another COVID-19 candidate vaccine
Biotechnology made in Cuba shows its strengths once again. The Center for Genetic Engineering and Biotechnology (CIGB) has submitted the technical file of their first vaccine candidate against COVID-19 to the State Center for the Control of Medicines, Medical Equipment and Devices (CECMED).
News »
The emergence of Soberana 1 is not a chance event
Since the beginning of the Revolution, the priority granted to scientific progress, with emphasis on the training of highly qualified human capital and the creation of research centers in dissimilar branches of knowledge, were essential prerequisites that allowed Cuba to venture into the promising sector of biotechnology in the decade of the 1980s, practically at the same time this industry was emerging in a small group of nations with greater technological development.
News »
BioCen develops secure medium to transport viral samples, a first in Cuba
Researchers at the National Biopreparations Center (BioCen) have developed Cuba’s first secure medium to transport viruses, created for use in the collection and transfer of patients’ nasopharyngeal and oropharyngeal samples for the diagnosis of SARS-COV-2, the COVID-19 causal agent. BioCen achieved and industrially scaled the product in only seven days and, subsequently received its Sanitary Registration from the State Center for the Control of Drugs, Equipment and Medical Devices (Cecmed).